PTF1A Human Pre-designed siRNA Set A contains three designed siRNAs for PTF1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGDR Human Pre-designed siRNA Set A contains three designed siRNAs for PTGDR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgdr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptgdr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGDR Rat Pre-designed siRNA Set A contains three designed siRNAs for PTGDR gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGDR2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGDR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgdr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptgdr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgdr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ptgdr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGDS Human Pre-designed siRNA Set A contains three designed siRNAs for PTGDS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGER1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGER1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGER2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGER2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGER3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGER3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGER4 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGER4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGES Human Pre-designed siRNA Set A contains three designed siRNAs for PTGES gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGES2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGES2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGES3 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGES3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGFR Human Pre-designed siRNA Set A contains three designed siRNAs for PTGFR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgfr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptgfr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgfr Rat Pre-designed siRNA Set A contains three designed siRNAs for Ptgfr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGFRN Human Pre-designed siRNA Set A contains three designed siRNAs for PTGFRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGIR Human Pre-designed siRNA Set A contains three designed siRNAs for PTGIR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgir Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptgir gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptgir Rat Pre-designed siRNA Set A contains three designed siRNAs for Ptgir gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGIS Human Pre-designed siRNA Set A contains three designed siRNAs for PTGIS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGR1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGR2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGS1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTGS2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTGS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTH Human Pre-designed siRNA Set A contains three designed siRNAs for PTH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

pTH-Related Protein (1-34) (human, mouse, rat), a fragment of parathyroid hormone-related protein, is an anabolic agent. pTH-Related Protein (1-34) (human, mouse, rat) can be used for postmenopausal osteoporosis study[1].

PTH1R Human Pre-designed siRNA Set A contains three designed siRNAs for PTH1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTH2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTH2R Human Pre-designed siRNA Set A contains three designed siRNAs for PTH2R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTHLH Human Pre-designed siRNA Set A contains three designed siRNAs for PTHLH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTK2 Human Pre-designed siRNA Set A contains three designed siRNAs for PTK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ptk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ptk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTK2B Human Pre-designed siRNA Set A contains three designed siRNAs for PTK2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTK6 Human Pre-designed siRNA Set A contains three designed siRNAs for PTK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTK7 Human Pre-designed siRNA Set A contains three designed siRNAs for PTK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PTK7/β-catenin-IN-1 (compound 01065) is a potent PTK7/β-catenin inhibitor with an IC50 of 8.9 μM and 56.5 μM for PTK7/β-catenin and p53/MDM2, respectively. PTK7/β-catenin-IN-1 has the potential for cancer research[1].

PTK7/β-catenin-IN-1 (compound 01065) is a potent PTK7/β-catenin inhibitor with an IC50 of 8.9 μM and 56.5 μM for PTK7/β-catenin and p53/MDM2, respectively. PTK7/β-catenin-IN-1 has the potential for cancer research[1].

PTK7/β-catenin-IN-1 (compound 01065) is a potent PTK7/β-catenin inhibitor with an IC50 of 8.9 μM and 56.5 μM for PTK7/β-catenin and p53/MDM2, respectively. PTK7/β-catenin-IN-1 has the potential for cancer research[1].

PTK7/β-catenin-IN-1 (compound 01065) is a potent PTK7/β-catenin inhibitor with an IC50 of 8.9 μM and 56.5 μM for PTK7/β-catenin and p53/MDM2, respectively. PTK7/β-catenin-IN-1 has the potential for cancer research[1].

PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin (IC50: 5.6 μM), thereby inhibiting the signaling of the Wnt/β-catenin pathway. PTK7/β-catenin-IN-2 targets cell growth dependent on the Wnt signaling pathway and has anticancer properties. PTK7/β-catenin-IN-2 also showed inhibitory potency against p53 and MDM2 binding with an IC50 of […]

PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin (IC50: 5.6 μM), thereby inhibiting the signaling of the Wnt/β-catenin pathway. PTK7/β-catenin-IN-2 targets cell growth dependent on the Wnt signaling pathway and has anticancer properties. PTK7/β-catenin-IN-2 also showed inhibitory potency against p53 and MDM2 binding with an IC50 of […]

PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin (IC50: 5.6 μM), thereby inhibiting the signaling of the Wnt/β-catenin pathway. PTK7/β-catenin-IN-2 targets cell growth dependent on the Wnt signaling pathway and has anticancer properties. PTK7/β-catenin-IN-2 also showed inhibitory potency against p53 and MDM2 binding with an IC50 of […]

PTK7/β-catenin-IN-2 (compound 04967) is an inhibitor of PTK7/β-catenin. It inhibits the binding of PTK7 to β-catenin (IC50: 5.6 μM), thereby inhibiting the signaling of the Wnt/β-catenin pathway. PTK7/β-catenin-IN-2 targets cell growth dependent on the Wnt signaling pathway and has anticancer properties. PTK7/β-catenin-IN-2 also showed inhibitory potency against p53 and MDM2 binding with an IC50 of […]

PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC)[1].

PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC)[1].

PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC)[1].